New activities of homoyessotoxin against lung cancer through the regulation of EGFR/PI3K/AKT pathway

Key Points

• Homoyessotoxin exhibits significant anti-cancer activity against lung cancer.
• Key findings reveal that homoyessotoxin affects the regulation of the EGFR/PI3K/AKT pathway.
• This study utilized in vitro models to explore the interaction between homoyessotoxin and lung cancer cells.
• The findings highlight the potential for homoyessotoxin as a therapeutic agent in lung cancer treatment.